AGLE Annual Total Long Term Liabilities
$6.18 M
+$342.00 K+5.86%
31 December 2022
Summary:
As of February 5, 2025, AGLE annual total long term liabilities is $6.18 million, with the most recent change of +$342.00 thousand (+5.86%) on December 31, 2022. During the last 3 years, it has risen by +$1.44 million (+30.36%).AGLE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGLE Quarterly Long Term Liabilities
$407.80 M
+$189.13 M+86.49%
30 September 2023
Summary:
As of February 5, 2025, AGLE quarterly total long term liabilities is $407.80 million, with the most recent change of +$189.13 million (+86.49%) on September 30, 2023. Over the past year, it has increased by +$401.46 million (+6339.21%).AGLE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGLE Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.9% | +6339.2% |
| 3 y3 years | +30.4% | +8042.9% |
| 5 y5 years | +5470.3% | +10000.0% |
AGLE Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | at high |
Aeglea BioTherapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $407.80 M(+86.5%) |
| June 2023 | - | $218.66 M(+3447.4%) |
| Mar 2023 | - | $6.16 M(-0.3%) |
| Dec 2022 | $6.18 M(+5.9%) | $6.18 M(-2.4%) |
| Sept 2022 | - | $6.33 M(-5.3%) |
| June 2022 | - | $6.69 M(+28.2%) |
| Mar 2022 | - | $5.21 M(-10.7%) |
| Dec 2021 | $5.84 M(+9.3%) | $5.84 M(-10.9%) |
| Sept 2021 | - | $6.55 M(-10.9%) |
| June 2021 | - | $7.35 M(-1.8%) |
| Mar 2021 | - | $7.49 M(+40.2%) |
| Dec 2020 | $5.34 M(+12.7%) | $5.34 M(+6.7%) |
| Sept 2020 | - | $5.01 M(+5.1%) |
| June 2020 | - | $4.76 M(-1.6%) |
| Mar 2020 | - | $4.84 M(+2.0%) |
| Dec 2019 | $4.74 M | $4.74 M(-3.3%) |
| Sept 2019 | - | $4.91 M(+0.9%) |
| June 2019 | - | $4.86 M(+1046.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $424.00 K(+488.9%) |
| Dec 2018 | $72.00 K(-35.1%) | $72.00 K(-11.1%) |
| Sept 2018 | - | $81.00 K(-11.0%) |
| June 2018 | - | $91.00 K(-9.9%) |
| Mar 2018 | - | $101.00 K(-9.0%) |
| Dec 2017 | $111.00 K(-15.9%) | $111.00 K(-5.1%) |
| Sept 2017 | - | $117.00 K(-4.1%) |
| June 2017 | - | $122.00 K(-3.9%) |
| Mar 2017 | - | $127.00 K(-3.8%) |
| Dec 2016 | $132.00 K(+388.9%) | $132.00 K(+407.7%) |
| Sept 2016 | - | $26.00 K(+62.5%) |
| June 2016 | - | $16.00 K(-27.3%) |
| Mar 2016 | - | $22.00 K(-18.5%) |
| Dec 2015 | $27.00 K(>+9900.0%) | $27.00 K(-15.6%) |
| Sept 2015 | - | $32.00 K(-13.5%) |
| June 2015 | - | $37.00 K(-11.9%) |
| Mar 2015 | - | $42.00 K(>+9900.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00 |
| Dec 2013 | $0.00 | - |
FAQ
- What is Aeglea BioTherapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics annual total long term liabilities year-on-year change?
- What is Aeglea BioTherapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics quarterly long term liabilities year-on-year change?
What is Aeglea BioTherapeutics annual total long term liabilities?
The current annual total long term liabilities of AGLE is $6.18 M
What is the all time high annual total long term liabilities for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high annual total long term liabilities is $6.18 M
What is Aeglea BioTherapeutics annual total long term liabilities year-on-year change?
Over the past year, AGLE annual total long term liabilities has changed by +$342.00 K (+5.86%)
What is Aeglea BioTherapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of AGLE is $407.80 M
What is the all time high quarterly long term liabilities for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high quarterly total long term liabilities is $407.80 M
What is Aeglea BioTherapeutics quarterly long term liabilities year-on-year change?
Over the past year, AGLE quarterly total long term liabilities has changed by +$401.46 M (+6339.21%)